Cart summary

You have no items in your shopping cart.

Frovatriptan Succinate

SKU: orb1705075

Description

Frovatriptan Succinate is a selective agonist of 5-HT1B/1D receptors used for the acute treatment of migraine. It is employed in research to investigate migraine pathophysiology and triptan pharmacology through in vitro receptor binding assays and in vivo animal models of neurovascular activation.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number158930-09-7
MW379.41
FormulaC18H25N3O6
SMILESC(CC(O)=O)C(O)=O.C(N)(=O)C=1C=C2C3=C(NC2=CC1)CC[C@@H](NC)C3
Target5-HT Receptor,Others

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Frovatriptan succinate hydrate [orb1309659]

    99.95%

    158930-17-7

    379.41

    C18H25N3O6

    5 mg, 10 mg, 100 mg, 2 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Frovatriptan Succinate (orb1705075)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%